Skip to main content
EXO-PAN • RESEARCH USE ONLY

Insulin-Secreting Pancreatic Beta Exosomes

Exosomes from insulin-secreting beta cells, enriched with beta-cell–specific regulatory molecules and insulin-related miRNAs.

Product image for Insulin-Secreting Pancreatic Beta Exosomes
Beta-cell EV program
ISLET-SPECIFIC CARGO
— Released from insulin-secreting beta cells and enriched for beta-lineage regulatory molecules plus insulin-related miRNAs.
Glucose metabolism axis
METABOLIC MODULATION
— Discussed for tuning systemic glucose handling while protecting residual islets from inflammatory stressors.
Autoimmune islet calm
IMMUNE–METABOLIC INTERFACE
— Used to blunt autoimmune targeting of beta cells, support insulin sensitivity, and extend protective signaling to diabetic nephropathy models.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenousIMIntramuscular
Quantities
400 Billion Exosomes1ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Islet Inflammation
  • Diabetic Nephropathy

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup